ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cancer

The ACR’s State-of-the-Art Clinical Symposium: Stem Cell Therapy in Autoimmune Disease Evolution, Insights

Thomas R. Collins  |  July 14, 2015

CHICAGO—Stem cell transplantation for systemic sclerosis patients has come a long way over the past decade, with more finely calibrated dosing and better patient selection, said George Georges, MD, associate member of the Fred Hutchinson Cancer Research Center and associate professor in the medical oncology division at the University of Washington School of Medicine, Seattle,…

Filed under:ConditionsEducation & TrainingMeeting ReportsProfessional TopicsSystemic Sclerosis Tagged with:AC&RAutoimmune diseaseclinical symposiumrheumatologiststem cell therapytransplantation

The ACR’s State-of-the-Art Clinical Symposium: Rheumatic, Malignant Disease Mimics Call for Diligence from Rheumatologists

Thomas R. Collins  |  July 14, 2015

CHICAGO—David Daikh, MD, PhD, professor of medicine at the University of California San Francisco and chief of the Rheumatology Division at the San Francisco VA Medical Center, said the overlap between malignant disease and rheumatic disease means rheumatologists should stay aware that more may be going on than just a rheumatic disorder. He made his…

Filed under:ConditionsMeeting Reports Tagged with:AC&Rclinical symposiumDiagnosisDiseasemalignantmimicspatient carerheumaticrheumatologistTreatment

The ACR’s State-of-the-Art Clinical Symposium: Rheumatologists Weigh in on Tough-to-Treat Cases, Paget’s Disease, Imaging

Thomas R. Collins  |  July 14, 2015

CHICAGO—A 49-year-old woman has had RA for eight years. She has a rheumatoid factor reading of 35, an aCCP reading of 160, erythrocyte sedimentation rate of 42, plus erosions. She has been on methotrexate. She tried etanercept for six months, but then it stopped working. She was on 40 mg of adalimumab weekly, but it…

Filed under:ConditionsMeeting Reports Tagged with:combination therapydrugimagingoutcomePaget’s diseasepatient careRheumatic Diseaserheumatologisttoxicity

Many Healthcare Providers Come to Work Sick

Kathryn Doyle  |  July 7, 2015

(Reuters Health)—Many doctors, nurses, midwives and physician assistants come to work sick even though they know it puts patients at risk, a new survey hints. Many said they don’t call in sick because they don’t want to let colleagues or patients down by taking a sick day, and they were concerned about finding staff to…

Filed under:Practice SupportWorkforce Tagged with:immunocompromisedphysician practicesPractice Managementrheumatologists

Guselkumab Studied to Treat RA & Plaque Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2015

In a Phase 2 study, researchers evaluated the effectiveness of guselkumab to alleviate symptoms in patients with active RA suffering from tender and swollen joints.

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:EULARguselkumabMethotrexateplaque psoriasisRheumatoid arthritisustekinumab

International Consensus Statement on the Management & Treatment of IgG4-Related Disease

Arthritis & Rheumatology  |  June 30, 2015

IgG4-related disease (IgG4-RD) is an immune-mediated fibro-inflammatory condition that affects multiple organs and can lead to tumefactive, tissue-destructive lesions and organ failure. An international panel of experts has released a consensus statement on its management…

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Arthritis & RheumatologyIgG4-RDResearchTreatment

Medicare Paid Doctors $90 Billion in 2013, up 17%

Reuters Staff  |  June 3, 2015

NEW YORK (Reuters)—Medicare, the government-run health insurance program for elderly and disabled Americans, paid physicians $90 billion in 2013, up 17% from $77 billion in 2012, U.S. healthcare officials reported on Monday. Physician payments accounted for less than one-fifth of Medicare’s 2013 net outlays of $492 billion, which rose from $466 billion in 2012. Payments to…

Filed under:Practice Support Tagged with:MedicarePractice Management

Anti-TNF Agents May Improve Clinical Symptoms of Ankylosing Spondylitis

Lara C. Pullen, PhD  |  May 21, 2015

Ankylosing spondylitis primarily affects the joints and ligaments of the spine, but may also have an impact on other joints. Patients experience pain and stiffness that limit mobility in the back and other affected joints. Symptoms can come and go, last for long periods of time and be severe. Anti-tumor necrosis factor (anti-TNF) drugs are…

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesOther Rheumatic ConditionsResearch Rheum Tagged with:Ankylosing Spondylitisanti-tumor necrosis factorDrugsinflammationpatient careResearchtherapy

Rheumatologists on the Move

Ann-Marie Lindstrom  |  May 15, 2015

Maura Daly Iversen Named Catherine Worthingham Fellow by APTA Maura Daly Iversen, PT, DPT, SD, MPH, FNAP, FAPTA, associate editor of The Rheumatologist, was recently named a Catherine Worthingham Fellow—the highest honor among the American Physical Therapy Association (APTA) membership categories. According to the award announcement, Worthingham “motivated others to make an impact within the…

Filed under:Professional TopicsProfiles Tagged with:appointmentsAwardsCareerrheumatologist

Plaquenil: From Malaria Treatment to Managing Lupus, RA

Charles Radis, DO  |  May 15, 2015

In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine (Plaquenil), for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes. I presented the case to my attending, Steven Malawista, MD, at the Yale…

Filed under:ConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:drugLupusPlaquenilRheumatoid arthritis

  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 86
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences